CD8A and cancer: Furthermore, the immune response against cancer cells is hampered by oxygen-sensitive prolyl hydroxylase (PHD) protein in T cells, which suppresses Th1 response, stimulates CD4+ regulatory T (Treg) cell induction, and dampens CD8+ T cell effector function.